Yes. Immune Targeting Systems was formerly owned by 1 private investor.
Immune Targeting Systems is headquartered in London, United Kingdom.
Immune Targeting Systems is a life science company.
Immune Targeting Systems was founded in 2003.
2 Royal College Street,
London,
NW1 0NH
United Kingdom,
+44 20 7691 4908
Immune Targeting Systems Ltd. develops synthetic vaccines for mutating viruses. Immune Targeting Systems enabling the T-cell vaccine platform enables it to target highly conserved parts of the virus (“antigens”) and direct a T-cell immune response to those cells in the body infected with one of these difficult viruses. Immune Targeting Systems was founded in 2003 and is based in London, United Kingdom.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
